CompletedNCT06405152

Assessment of Macrophage Activation syndromE in STill's Disease

Studying Adult-onset Still disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Swedish Orphan Biovitrum
Principal Investigator
Uwe Ullman, MD
Swedish Orphan Biovitrum AG Riehenring 182, 4058 Basel, Switzerland
Intervention
Chart review(other)
Enrollment
75 enrolled
Eligibility
80 years · All sexes
Timeline
20232024

Study locations (11)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06405152 on ClinicalTrials.gov

Other trials for Adult-onset Still disease

Additional recruiting or active studies for the same condition.

See all trials for Adult-onset Still disease

← Back to all trials